NIH Grants Exclusive License for Powered Walking Aids Tech
Published Date: 2/27/2026
Notice
Summary
The National Institutes of Health plans to give Bionic Power Inc. an exclusive license to use new technology that helps people walk better, especially those with movement problems. This means Bionic Power can develop and sell these powered gait assistance systems worldwide. If you want to comment or apply for a license, you need to act by March 16, 2026.
Analyzed Economic Effects
3 provisions identified: 1 benefits, 1 costs, 1 mixed.
Exclusive License for Gait Devices
The National Institutes of Health is contemplating granting Bionic Power Inc. an exclusive, royalty-bearing patent license to practice listed inventions for "Powered Gait Assistance Systems". The prospective exclusive license territory may be worldwide where patent rights exist and the field of use is limited to "the treatment of human movement disorders."
Royalty Requirement and Confidentiality
The prospective exclusive license will be royalty-bearing. License applications filed in response to this notice will be presumed to contain business confidential information and will be released only as required under the Freedom of Information Act; public comments (not part of license applications) will not be treated confidentially and may be made publicly available.
Deadline to Apply or Comment
If you want to apply for a license or comment on the contemplated exclusive license, written comments and/or license applications must be received by the NCI Technology Transfer Center on or before March 16, 2026. Complete license applications timely filed will be treated as objections to the grant.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-13244 — The Federal Demonstration Partnership; Phase VIII Notice
The Federal Demonstration Partnership (FDP) is inviting colleges, universities, research groups, and hospitals that get federal research money to join its Phase VIII starting in 2027. This phase will keep testing new ways to make research funding and rules easier and faster. Applications are due by September 15, 2026, with the program running through the end of 2032.
2026-13311 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late July 2026 to review grant applications and contract proposals. These meetings protect private info and trade secrets while deciding who gets funding. Researchers and organizations applying for grants or contracts should watch these dates closely, as funding decisions could impact their projects and budgets.
2026-13337 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings on July 24, 2026, to review and evaluate important grant applications related to cancer, imaging, eye diseases, and reproductive health. These meetings protect private info and trade secrets, so they’re not open to the public. Researchers and organizations applying for grants should note the dates as these reviews impact funding decisions.
2026-13204 — Proposed Collection; 30-Day Comment Request; NIH Information Collection Forms to Support the Genetic Testing Registry (OD)
The NIH wants your thoughts on updating forms that help track genetic tests in their registry. If you’re involved in genetic testing or research, these changes could affect how you share info. You’ve got until July 30, 2026, to send in your comments—no cost, just your voice to help make things smoother and smarter!
2026-12844 — Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings on July 17, 2026, to review important grant applications. These meetings protect private info and trade secrets while deciding which science projects get funding. Researchers applying for grants in brain injury, neurobehavior, nanotech, and heart/lung studies should note these review dates and prepare accordingly.
2026-12843 — Government Owned Inventions Available for License: C8166-45 Cell Line
The National Cancer Institute is offering a special human T-cell line called C8166-45 for licensing. This cell line helps scientists study viruses like HTLV-1 and HIV, which can cause serious diseases. Researchers and companies can now use this tool to develop better treatments, with licensing info available starting June 2026—no patents, just pure science power ready to roll!
Previous / Next Documents
Previous: 2026-03992 — Meeting of the Great Lakes St. Lawrence Seaway Development Corporation (GLS) Advisory Board
The Great Lakes St. Lawrence Seaway Development Corporation is hosting a virtual public meeting on March 26, 2026, to discuss important updates and plans for the Seaway. Anyone interested, especially businesses and communities relying on the Seaway, can join, speak, or submit materials by early March. This meeting helps shape future decisions that could impact shipping and regional economies.
Next: 2026-03997 — Submission for Review: 3206-0237, Information and Instructions on Your Reconsideration Rights, RI 38-47
The Office of Personnel Management is asking for public feedback on the instructions about how federal employees can ask for a second look at decisions about their retirement, health benefits, or life insurance. This update keeps the process clear and easy to follow, with no new costs or deadlines added. If you’re a federal employee or retiree, now’s the time to share your thoughts before April 28, 2026!